Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

712468

	registered interest
	date	20/03/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will make it his policy to make continuous glucose monitors available on the NHS.
	tabling member constituency	Wellingborough
	tabling member printed	Mr Peter Bone
	uin	68467
	answer	answer is ministerial correction date of answer 23/03/2017 answer text <p>Clinical commissioning groups (CCGs) are primarily responsible for commissioning diabetes services to meet the requirements of their populations. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, and are based on the available evidence, taking into account national guidelines. This should include consideration of access to continuous glucose monitoring for people with type 1 diabetes who might benefit from it.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 23/03/2017 09:48:15 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	1581 label Biography information for Mr Peter Bone

687062

	registered interest
	date	08/02/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when NICE plans to report on the availability of FreeStyle Libre on the NHS.
	tabling member constituency	Tynemouth
	tabling member printed	Mr Alan Campbell
	uin	63557
	answer	answer is ministerial correction date of answer 20/02/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) is developing a medtech innovation briefing (MIB) on FreeStyle Libre which it expects to publish in May 2017. NICE MIBs provide information on device and diagnostic technologies to aid local decision-making by clinicians, managers and procurement professionals. They contain no judgement on the value of the technology and they do not contain a recommendation from NICE.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 20/02/2017 12:01:45 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	529 label Biography information for Sir Alan Campbell

778221

	registered interest
	date	26/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the effect of flash glucose monitoring on the management of diabetes.
	tabling member constituency	Tynemouth
	tabling member printed	Mr Alan Campbell
	uin	109900
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>Freestyle Libre, a flash glucose monitoring system has been approved for reimbursement on National Health Service prescription from 1 November 2017 through listing in Part IX of the NHS England and Wales Drug Tariff.</p><p> </p><p>The NHS Business Services Authority carries out the assessment of Part IX applications made by manufacturers on behalf, of the Secretary of State for Health, for prescribing at NHS expense by an appropriate practitioner.</p><p> </p><p>The listing of a medical device in the Drug Tariff should not be interpreted as a recommendation to prescribe a particular product. Patients will need to discuss the ongoing management of their condition with their healthcare professional and consider whether flash glucose monitoring is suitable for them.</p><p> </p><p>Any device made available for prescribing to patients through listing in Part IX is required to meet set criteria, namely that the product is safe and of good quality, it is appropriate for general practice and, if relevant, non-medical prescribing, and it is cost effective.</p><p> </p><p>Within its financial constraints, the NHS is committed to providing access to new drugs and medical technologies. Ultimately it is for clinical commissioning groups (CCGs), who are primarily responsible for commissioning diabetes services, to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population and are based on the available evidence and take into account national guidelines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 109901 question first answered 03/11/2017 11:47:02 answering member 4067 label Biography information for Steve Brine
	tabling member	529 label Biography information for Sir Alan Campbell

778222

	registered interest
	date	26/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department takes to ensure that people with diabetes have access to new and emerging technologies as they come to market.
	tabling member constituency	Tynemouth
	tabling member printed	Mr Alan Campbell
	uin	109901
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>Freestyle Libre, a flash glucose monitoring system has been approved for reimbursement on National Health Service prescription from 1 November 2017 through listing in Part IX of the NHS England and Wales Drug Tariff.</p><p> </p><p>The NHS Business Services Authority carries out the assessment of Part IX applications made by manufacturers on behalf, of the Secretary of State for Health, for prescribing at NHS expense by an appropriate practitioner.</p><p> </p><p>The listing of a medical device in the Drug Tariff should not be interpreted as a recommendation to prescribe a particular product. Patients will need to discuss the ongoing management of their condition with their healthcare professional and consider whether flash glucose monitoring is suitable for them.</p><p> </p><p>Any device made available for prescribing to patients through listing in Part IX is required to meet set criteria, namely that the product is safe and of good quality, it is appropriate for general practice and, if relevant, non-medical prescribing, and it is cost effective.</p><p> </p><p>Within its financial constraints, the NHS is committed to providing access to new drugs and medical technologies. Ultimately it is for clinical commissioning groups (CCGs), who are primarily responsible for commissioning diabetes services, to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population and are based on the available evidence and take into account national guidelines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 109900 question first answered 03/11/2017 11:47:02 answering member 4067 label Biography information for Steve Brine
	tabling member	529 label Biography information for Sir Alan Campbell

539582

	registered interest
	date	18/07/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans his Department has to make personal devices for instant monitoring of insulin levels available to people with diabetes on the NHS.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	43045
	answer	answer is ministerial correction date of answer 25/07/2016 answer text <p>We are not aware of any clinical utility associated with the instant monitoring of insulin levels. However, continuous glucose monitoring devices can measure glucose levels 24 hours a day and it is for National Health Service commissioners to decide whether to make these available to their local populations.</p><p> </p><p>In August 2015, National Institute for Health and Care Excellence (NICE) published guidelines which recommend that such devices should not be made routinely available to people with Type 1 diabetes unless they are willing to commit to using them at least 70% of the time and to calibrate them as needed (as well as meeting certain other criteria).</p><p> </p><p>NICE has found that, for some people, continuous glucose monitoring can have clinical benefit but generally it is not more effective than current methods of self-monitoring.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 25/07/2016 16:14:14 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	4131 label Biography information for Jim Shannon

810654

	registered interest
	date	21/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department plans to introduce automatic insulin delivery devices for people who live with diabetes; and if he will make a statement.
	tabling member constituency	South Antrim
	tabling member printed	Paul Girvan
	uin	120999
	answer	answer is ministerial correction date of answer 09/01/2018 answer text <p>Clinical commissioning groups (CCGs) are primarily responsible for commissioning diabetes services. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, are based on the available evidence, and take into account national guidelines. This would apply to automatic insulin delivery devices, which would need to be both licensed and assessed for clinical and cost-effectiveness.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/01/2018 16:11:10 answering member 4067 label Biography information for Steve Brine
	tabling member	4633 label Biography information for Paul Girvan

579506

	registered interest
	date	09/09/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans his Department has to make continuous glucose monitoring and insulin pump technology available to diabetics on the NHS.
	tabling member constituency	Leicester East
	tabling member printed	Keith Vaz
	uin	45827
	answer	answer is ministerial correction date of answer 16/09/2016 answer text <p>This Government is working hard to improve outcomes and quality of life for those already living with diabetes and those who will develop it in the coming years. One of our key goals in the mandate to the National Health Service is a measurable reduction in variation in the management and care of people with the condition within the lifetime of this Parliament. Funding has been secured through the spending review to help achieve this and NHS England is developing a programme to ensure that those clinical commissioning groups (CCGs) which need extra investment in this area, accompanied by sound plans for delivery, receive it.</p><p> </p><p>In addition, the Clinical Commissioning Group Improvement and Assessment Framework will play a key role in delivering this as it contains two recognised evidence based measures of whether patients with diabetes are being supported to successfully manage their condition (achievement of the National Institute for Health and Care Excellence treatment targets and participation in structured education programmes).</p><p> </p><p>Using data from the NHS Atlas of Variation, NHS Right Care is also working with CCGs and other local partners to make improvements in diabetes care and reduce variation by providing hands on practical support.</p><p> </p><p>Since 2009/10, there has been an almost 70% increase in the proportion of people newly diagnosed with diabetes recorded as being referred to structured education courses, designed to help them manage their condition in the long term. However, whilst we know that the data on take up needs improving, there is still much further to go in enabling people with diabetes to access these programmes.</p><p> </p><p>The Department, NHS England and Diabetes UK are working on ways to improve the take up of structured education including exploring how more diversity of provision might be delivered through digital and web based approaches. The Department recently held a seminar with key stakeholders to identify actions that would facilitate improved access.</p><p> </p><p>CCGs are primarily responsible for commissioning diabetes services to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, are based on the available evidence, taking into account national guidelines. This should include consideration of access to continuous glucose monitoring for people with Type 1 diabetes who might benefit from it.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 45823 45828 question first answered 16/09/2016 14:49:02 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	338 label Biography information for Keith Vaz

595780

	registered interest
	date	07/10/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many people (a) have access to and (b) use an insulin pump.
	tabling member constituency	Leicester East
	tabling member printed	Keith Vaz
	uin	46832
	answer	answer is ministerial correction date of answer 13/10/2016 answer text <p>Data on insulin pump usage in England is now collected and published in the National Diabetes Insulin Pump Audit. The report for 2013-15 can be found at:</p><p><a href="http://www.hqip.org.uk/public/cms/253/625/19/520/National%20Diabetes%20Insulin%20Pump%20Audit%20report%202013-15.pdf?realName=hOfPw8.pdf?v=0" target="_blank">http://www.hqip.org.uk/public/cms/253/625/19/520/National%20Diabetes%20Insulin%20Pump%20Audit%20report%202013-15.pdf?realName=hOfPw8.pdf?v=0</a></p><p>Participation in the first audit was low, with 44 out of 183 units providing data, and so it does not provide an accurate count of the number of people using an insulin pump. Furthermore, the data does not provide information on access to insulin pumps or distinguish between insulin pumps provided by the National Health Service or those which are self-funded. This information is not collected centrally.</p><p>Information on the number of people using continuous glucose monitors is not collected centrally.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 46833 46834 question first answered 13/10/2016 13:15:20 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	338 label Biography information for Keith Vaz

595781

	registered interest
	date	07/10/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many people use a continuous glucose monitor (a) provided by the NHS and (b) that they have funded themselves.
	tabling member constituency	Leicester East
	tabling member printed	Keith Vaz
	uin	46833
	answer	answer is ministerial correction date of answer 13/10/2016 answer text <p>Data on insulin pump usage in England is now collected and published in the National Diabetes Insulin Pump Audit. The report for 2013-15 can be found at:</p><p><a href="http://www.hqip.org.uk/public/cms/253/625/19/520/National%20Diabetes%20Insulin%20Pump%20Audit%20report%202013-15.pdf?realName=hOfPw8.pdf?v=0" target="_blank">http://www.hqip.org.uk/public/cms/253/625/19/520/National%20Diabetes%20Insulin%20Pump%20Audit%20report%202013-15.pdf?realName=hOfPw8.pdf?v=0</a></p><p>Participation in the first audit was low, with 44 out of 183 units providing data, and so it does not provide an accurate count of the number of people using an insulin pump. Furthermore, the data does not provide information on access to insulin pumps or distinguish between insulin pumps provided by the National Health Service or those which are self-funded. This information is not collected centrally.</p><p>Information on the number of people using continuous glucose monitors is not collected centrally.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 46832 46834 question first answered 13/10/2016 13:15:20 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	338 label Biography information for Keith Vaz

595782

	registered interest
	date	07/10/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many people use an insulin pump (a) provided by the NHS and (b) that they have funded themselves.
	tabling member constituency	Leicester East
	tabling member printed	Keith Vaz
	uin	46834
	answer	answer is ministerial correction date of answer 13/10/2016 answer text <p>Data on insulin pump usage in England is now collected and published in the National Diabetes Insulin Pump Audit. The report for 2013-15 can be found at:</p><p><a href="http://www.hqip.org.uk/public/cms/253/625/19/520/National%20Diabetes%20Insulin%20Pump%20Audit%20report%202013-15.pdf?realName=hOfPw8.pdf?v=0" target="_blank">http://www.hqip.org.uk/public/cms/253/625/19/520/National%20Diabetes%20Insulin%20Pump%20Audit%20report%202013-15.pdf?realName=hOfPw8.pdf?v=0</a></p><p>Participation in the first audit was low, with 44 out of 183 units providing data, and so it does not provide an accurate count of the number of people using an insulin pump. Furthermore, the data does not provide information on access to insulin pumps or distinguish between insulin pumps provided by the National Health Service or those which are self-funded. This information is not collected centrally.</p><p>Information on the number of people using continuous glucose monitors is not collected centrally.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 46832 46833 question first answered 13/10/2016 13:15:20 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	338 label Biography information for Keith Vaz